作者
Michael Abouyannis, Hanif Esmail, Mainga Hamaluba, Mwanajuma Ngama, Hope Mwangudzah, Noni Mumba, K Yeri Betty, Salim Mwalukore, Hassan J Alphan, Dinesh Aggarwal, Gabriel Alcoba, Nick Cammack, Jean-Philippe Chippaux, Matthew E Coldiron, José M Gutiérrez, Abdulrazaq G Habib, Robert A Harrison, Geoffrey K Isbister, Eric J Lavonas, Diogo Martins, Isabela Ribeiro, James A Watson, David J Williams, Nicholas R Casewell, Sarah A Walker, David G Lalloo, A Sarah Walker, Chanaveerappa Bammigatti, Rebecca W Carter, Charles J Gerardo, H Janaka de Silva, Thomas Lamb, Matthew R Lewin, Wuelton Monteiro, Ymkje Stienstra
发表日期
2023/2/1
来源
The Lancet Global Health
卷号
11
期号
2
页码范围
e296-e300
出版商
Elsevier
简介
Snakebite clinical trials have often used heterogeneous outcome measures and there is an urgent need for standardisation. A globally representative group of key stakeholders came together to reach consensus on a globally relevant set of core outcome measurements. Outcome domains and outcome measurement instruments were identified through searching the literature and a systematic review of snakebite clinical trials. Outcome domains were shortlisted by use of a questionnaire and consensus was reached among stakeholders and the patient group through facilitated discussions and voting. Five universal core outcome measures should be included in all future snakebite clinical trials—mortality, WHO disability assessment scale, patient-specific functional scale, acute allergic reaction by Brown criteria, and serum sickness by formal criteria. Additional syndrome-specific core outcome measures should be …
引用总数
学术搜索中的文章
M Abouyannis, H Esmail, M Hamaluba, M Ngama… - The Lancet Global Health, 2023